Key result
Inherited thrombophilia linked to ~660% higher symptomatic VTE risk in relatives of pediatric VTE patients.
Why the study?
Does the presence of inherited thrombophilia increase the risk of symptomatic VTE in relatives of pediatric VTE patients?
Observational (n=533)
Does the presence of inherited thrombophilia increase the risk of symptomatic VTE in relatives of pediatric VTE patients?
Answers are grounded in this paper and cite their sources.
Relatives of pediatric VTE patients who carry inherited thrombophilias, particularly antithrombin, protein C, or protein S deficiency, have a substantially increased risk of symptomatic VTE, supporting targeted screening in this population.
Screening for inherited thrombophilia (IT) is controversial; persons at high risk for venous thromboembolism (VTE) who benefit from screening need to be identified. We tested 533 first- and second-degree relatives of 206 pediatric VTE patients for IT (antithrombin, protein C, protein S, factor V G1691A, factor II G20210A) and determined the incidence of symptomatic VTE relative to their IT status. The risk for VTE was significantly increased among family members with, versus without, IT (hazard ratio = 7.6; 95% confidence interval [CI], 4.0-14.5; P < .001) and highest among carriers of antithrombin, protein C, or protein S deficiency (hazard ratio = 25.7; 95% CI, 12.2-54.2; P < .001). Annual incidences of VTE were 2.82% (95% CI, 1.63%-4.80%) among family members found to be carriers of antithrombin, protein C, or protein S deficiency, 0.42% (0.12%-0.53%) for factor II G202010A, 0.25% (0.12%-0.53%) for factor V G1691A, and 0.10% (0.06%-0.17%) in relatives with no IT. Given the high absolute risk of VTE in relatives with protein C, protein S, and antithrombin deficiency, we suggest screening for these forms of hereditary thrombophilia in children with VTE and their relatives. Interventional studies are required to assess whether thromboembolism can be prevented in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Holzhauer et al. (2012) conducted an observational in Venous thromboembolism (VTE) (n=533). Inherited thrombophilia vs. No inherited thrombophilia was evaluated on Symptomatic VTE (HR 7.6, 95% CI 4.0-14.5, p=< .001). Inherited thrombophilia increased the risk of symptomatic VTE among relatives of pediatric VTE patients compared to those without thrombophilia.
Synapse has enriched 10 related papers. Consider them for comparative context: